Profile data is unavailable for this security.
About the company
Quantum Genomics SA is a France-based company. The Company is a biopharmaceutical company dedicated to developing new therapies for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure. Its main activity is in research and development of new therapies for the treatment of hypertension, BAPAI (Brain Aminopeptidase A Inhibitors) oriented in the field of cardiovascular diseases, especially high blood pressure and heart failure. The Company also co-develops products with academic teams, biotechnological research entities, and some of the pharmaceutical and bio-science companies. The Company is involved in four research programs. Quantum Genomics also collaborates with Center for Clinical Investigation 9201 APHP / INSERM of the Georges Pompidou European Hospital in Paris, among others.
- Revenue in EUR (TTM)0.00
- Net income in EUR-8.89m
- Incorporated2005
- Employees2.00
- LocationQuantum Genomics SA33 rue MarbeufPARIS 75008FranceFRA
- Phone+33 185347770
- Fax+33 175347778
- Websitehttps://quantum-genomics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IntegraGen SA | 6.69m | -1.55m | 1.28m | 39.00 | -- | 3.61 | -- | 0.191 | -0.2338 | -0.2338 | 1.01 | 0.0526 | 1.36 | 8.98 | 4.92 | 171,592.60 | -31.48 | -1.90 | -115.71 | -4.51 | 59.50 | 64.12 | -23.12 | -1.44 | 0.9581 | -- | 0.5447 | -- | -30.62 | 0.9904 | -49.22 | -- | -- | -- |
| Biophytis SA | 0.00 | -8.03m | 2.40m | 18.00 | -- | -- | -- | -- | -0.8431 | -0.8431 | 0.00 | -0.3326 | 0.00 | -- | -- | 0.00 | -104.73 | -99.99 | -- | -808.35 | -- | -- | -- | -- | -- | -34.32 | -- | -- | -- | -- | 39.04 | -- | -12.94 | -- |
| Quantum Genomics SA | 0.00 | -8.89m | 5.03m | 2.00 | -- | -- | -- | -- | -0.1276 | -0.1276 | 0.00 | -0.0352 | 0.00 | -- | -- | 0.00 | -433.64 | -70.24 | -858.41 | -123.45 | -- | -3,200.37 | -- | -3,364.53 | -- | -131.86 | 14.44 | -- | -100.00 | -- | -180.44 | -- | -- | -- |
| Plant Advanced Technologies PAT SA | 941.74k | 318.01k | 9.42m | 16.00 | 30.26 | 1.00 | 10.67 | 10.01 | 0.2776 | 0.2776 | 0.8377 | 8.38 | -- | -- | -- | 58,858.75 | -- | -1.51 | -- | -1.96 | 144.97 | 128.32 | 33.77 | -13.36 | 0.3156 | -- | 0.2867 | -- | 14.61 | 10.44 | 1,081.17 | -- | -- | -- |
| Oncodesign Precision Medicine Opm SA | 207.25k | 6.27m | 10.32m | 13.00 | 1.61 | 0.9735 | 1.58 | 49.80 | 0.3457 | 0.3457 | 0.0114 | 0.5732 | 0.0119 | -- | 0.2634 | 11,513.89 | 36.11 | -- | 54.21 | -- | 6,372.89 | -- | 3,026.21 | -- | 0.926 | 20.81 | 0.3859 | -- | -80.69 | -- | 10.89 | -- | -- | -- |
| Predilife SA | 728.07k | -3.80m | 12.62m | 27.00 | -- | -- | -- | 17.33 | -0.9936 | -0.9936 | 0.1905 | -1.26 | 0.3919 | -- | 3.63 | 36,421.71 | -204.34 | -93.24 | -- | -132.80 | 98.10 | 89.32 | -521.48 | -1,377.00 | -- | -19.99 | -- | -- | 55.20 | 84.82 | -0.9621 | -- | -24.35 | -- |
| Nfl Biosciences SAS | 0.00 | -3.15m | 14.80m | 4.00 | -- | 4.33 | -- | -- | -0.2779 | -0.2779 | 0.00 | 0.2699 | 0.00 | -- | -- | 0.00 | -66.86 | -75.08 | -91.01 | -121.22 | -- | -- | -- | -- | -- | -- | 0.0088 | -- | -- | -- | 44.44 | -- | -- | -- |
| Poxel SA | 7.66m | -13.66m | 15.70m | 5.00 | -- | -- | -- | 2.05 | -0.2594 | -0.2594 | 0.1443 | -1.14 | 1.45 | -- | 8.90 | 1,276,167.00 | -258.08 | -69.11 | -- | -133.51 | 52.02 | 80.83 | -178.45 | -475.98 | -- | -0.1862 | -- | -- | 234.98 | -24.22 | 47.83 | -- | -- | -- |
| Gensight Biologics SA | 194.00k | -15.12m | 17.52m | 13.00 | -- | -- | -- | 90.29 | -0.1293 | -0.1293 | 0.0016 | -0.245 | 0.0174 | -- | 10.78 | 16,166.67 | -135.38 | -81.19 | -- | -203.71 | -- | -- | -7,793.81 | -868.76 | -- | -- | -- | -- | 18.39 | 16.47 | 46.60 | -- | -57.94 | -- |
